The essential role of endometrial prostaglandin F2 alpha (PTGF) for induction of the corpus luteum (CL) regression is well documented in the cow. However, the acute effects of PTGF on known local luteotropic factors (oxytocin [OXT] and its receptor, insulin-like growth factor [IGF] 1, and progesterone and its receptor), the principal angiogenic factor vascular endothelial growth factor (VEGF) A and the capillary destabilization factor angiopoietin (ANGPT) 2 were not thoroughly studied in detail. The aim of this study was therefore to evaluate the tissue concentration of these factors during PTGF induced luteolysis. In addition the mRNA expression of progesterone receptor (PGR), OXT receptor (OXTR), IGF1, IGFBP1, ANGPT1, and ANGPT2 was determined at different times after PTGF treatment. Cows (n ¼ 5 per group) in the mid-luteal phase (Days 8-12, control group) were injected with the PTGF analog (cloprostenol), and CL were collected by transvaginal ovariectomy at 0.5, 2, 4, 12, 24, 48, and 64 h after injection. The mRNA expression was analyzed by quantitative real-time PCR, and the protein concentration was evaluated by enzyme immunoassay or radioimmunoassay. Progesterone concentrations, as well as mRNA expression of PGR, in CL tissue were significantly downregulated by 12 h after PTGF. Tissue OXT peptide and OXTR mRNA decreased significantly after 2 h, followed by a continuous decrease of OXT mRNA. IGF1 and VEGFA protein already decreased after 0.5 h. By contrast, the IGFBP1 mRNA was up-regulated significantly after 2 h to a high plateau. ANGPT2 protein and mRNA significantly increased during the first 2 h, followed by a steep decrease after 4 h. The acute decrease of local luteotropic activity and acute changes of ANGPT2 and VEGFA suggest that modulation of vascular stability may be a key component in the cascade of events leading to functional luteolysis.
INTRODUCTION
In ruminants, luteal regression is stimulated by episodic release of prostaglandin F2 alpha (PTGF) from the uterus which reaches the corpus luteum (CL) through a countercurrent system between uterine vein and ovarian artery. Luteolysis is characterized by a rapid decline in progesterone secretion, which is followed by degeneration of vasculature and apoptosis of steroidogenic cells [1] . Several researchers have suggested that reduced ovarian blood flow and decrease in luteal vascularity play a critical role in initiation of luteal regression [2, 3] . This is followed by a decrease in blood vessel density, and then the degeneration and disappearance of luteal cells [4] . The growth, differentiation, and regression of the CL depend on the balance between luteotropic and luteolytic, as well as angiogenic and antiangiogenic, factors. These, in turn, regulate the cyclical generation and regression of its vasculature. Thus, the life span of the CL involves several tightly regulated and transient proteolytic processes, which include tissue remodeling during angiogenesis and tissue degradation during angioregression [1, [5] [6] [7] [8] [9] . In the cow, the major luteotropic factor controlling luteal function is luteinizing hormone (LH), whereas the primary inducer of luteolysis is PTGF. Recently, we have shown that there is a very complex interaction between endocrine and locally produced growth factors in bovine CL during both these periods [7, 10] .
In the ovary, the primary proangiogenic factors are likely to be regulated by gonadotropins, steroids, and other growth factors [11] [12] [13] [14] . Some of the locally produced regulators of luteal angiogenesis also seem to be very important during luteal regression, and these include members of the following growth factor systems: vascular endothelial growth factor (VEGF) [15] [16] [17] , angiopoietin (ANGPT) [18] [19] [20] [21] , fibroblast growth factors (FGFs) [17, 22, 23] , insulin-like growth factor (IGF) [24] [25] [26] , nitric oxide [27, 28] , angiotensin and endothelin systems [5, [29] [30] [31] , extracellular matrix degrading proteases and different cytokines, apoptotic factors, and enzymes [10, [32] [33] [34] [35] . Most of these studies have been done at the end of functional luteolysis (about 12 h after PTGF administration) or during structural luteolysis (after 12 h). However, there is limited information on the early cascade of events directly after the PTGF administration surge.
Our hypothesis was that PTGF, acting on luteal cells directly, acutely regulates the production of factors that have luteotropic, angiogenic, or vascular-stabilizing effects. These then play a critical role in functional luteolysis. Therefore, the aim of this study was to evaluate the mRNA expression and the protein concentration for IGF1, oxytocin (OXT), and progesterone, as well as VEGFA and ANGPT2, in the CL at different times immediately following PTGF-induced luteolysis.
MATERIALS AND METHODS

Collection of Bovine Corpora Lutea During Induced Luteolysis
Previously estrus-synchronized cows (Holstein-Friesians and Brown Swiss), were injected i.m. with 500 lg of the PTGF analog, Cloprostenol (Estrumate; Intervet, Germany), at the mid-luteal phase (Days 8-12 ). The CL were collected by transvaginal ovariectomy at 0.5, 2, 4, 12, 24, 48, and 64 h (n ¼ 5 per time point) after PTGF injection [29] . The experiments were conducted according to the rules of the German animal welfare law, and were licensed by the local authorities. This is in accordance with the International Guiding Principles for Biomedical Research Involving Animals. Control bovine CL were collected from the slaughterhouse in the mid-luteal phase (Days 8-12; n ¼ 5/group). All CL were immediately frozen in liquid nitrogen and stored at À808C until RNA and protein extraction prior to analysis. Blood samples for progesterone determination were taken from the jugular vein.
Hormone Determination CL tissue extraction. Tissue (1 g) was transferred into 10 volumes of PBS containing one complete mini tablet of bovine serum albumin (Boehringer, Mannheim, Germany). This tablet contains both reversible and irreversible protease inhibitors, and inhibits a broad spectrum of serine-, cysteine-, and metalloproteases. The mixture was homogenized for 1 min using Ultra Turrax equipment (Jahnke and Kunkel, Staufen, Germany) on ice, and then kept in ice water for 1 h. After centrifugation for 10 min at 3500 3 g, the total protein content in the supernatant was determined by a BCA test (Sigma-Aldrich GmbH, Taufkirchen, Germany).
Enzyme Immunoassay for Progesterone and ANGPT2 Determination
Progesterone determination in blood and CL tissue. The concentration of progesterone in blood plasma was measured after extraction with petroleum ether by an enzyme immunoassay (EIA) technique [36] . The concentration of progesterone in CL was measured after extraction (see CL tissue extraction). The effective dose for 50% inhibition (ED 50 ) of the assay was 0.6 ng/ml. The standard curve for progesterone ranged from 0.05 to 25 ng/ml. The intra-assay coefficient of variation (CV) was 4%-5%, while the interassay CV was 8%-9%.
ANGPT2 determination in CL tissue. ANGPT2 was measured in CL tissue extracts by a commercial EIA kit (R&D systems, Minneapolis, MN), according to the manufacturer's instructions. The standard curve for ANGPT2 ranged from 50 to 3000 pg/ml, and the ED 50 of the assay was 750 pg/ml. The intra-and interassay CV values were below 6% and 10%, respectively.
Radioimmunoassay for VEGFA, IGF1, and OXT in CL Tissue VEGFA determination. The concentration of VEGFA in homogenate supernatant of CL tissue was determined by radioimmunoassay (RIA), as previously described by Berisha et al. [37] . It utilized a rabbit antiserum raised in our laboratory against recombinant bovine VEGF164 (kindly supplied by D. Gospodarowicz, Chiron Corp., Berkeley, CA). The antibody cross-reacts with all four human isoforms of VEGFA (VEGF121, VEGF165, VEGF189, and VEGF206). The cross-reactivity of the antibody to other growth factors, platelet-derived growth factor (PDGF)-AA, PDGFBB, PDGFAB, FGF1, FGF2, and transforming growth factor alpha was below 0.1%. Briefly, the standard curve for VEGFA ranged from 0.062 to 8 ng/ml, with an ED 50 of 0.6 ng/ml. The intra-and interassay CVs were below 6% and 14%, respectively. IGF1 determination. IGF1 was evaluated by RIA, as described by Einspanier et al. [38] , in tissue extract supernatant. The standard curve for IGF1 ranged from 0.078 to 10 ng/ml, and the ED 50 for the assay was 2.05 ng/ml. The intra-and interassay CVs were below 6% and 14%, respectively.
OXT determination. The concentration of OXT in homogenate supernatant of CL tissue was determined by RIA using a rabbit antiserum raised against OXT [39] . The RIA for OXT was evaluated in different dilutions of extracts. The standard curve for OXT ranged from 0.125 to 64 pg/0.1 ml, and the ED 50 of the assay was 3.7 pg/ml. The intra-and interassay CVs were 5.8%-7.4% and 10.5%-15.4%, respectively.
Isolation of Total RNA
Total RNA was prepared from CL tissue according to the methods described by Chomczynski and Sacchi [40] , using the TriPure isolation reagent (Roche Diagnostics, Mannheim, Germany). Possible DNA contamination was eliminated by additional DNase (Promega, Madison, WI) digestion according to the manufacturer's instructions. Total RNA was finally purified using Nucleospin RNA II (Macherey & Nagel, Düren, Germany), and checked for quantity and quality using a biophotometer at wavelengths of 260 and 260/280 nm, respectively (Eppendorf, Hamburg, Germany).
Degradation of the RNA was measured with the Agilent 2100 bioanalyzer (Agilent Technologies, Deutschland Gmbh, Waldbronn, Germany) in conjunction with the RNA 6000 Nano Assay, according to the manufacturer's instructions. The bioanalyzer enables the standardization of RNA quality control. RNA samples are electrophoretically separated on a microfabricated chip, and subsequently detected with laser-induced fluorescence induction. The Bioanalyzer electropherogram of total RNA shows two distinct ribosomal peaks corresponding to either 18S or 28S for eukaryotic RNA, and a relatively flat baseline between the 5S and 18S ribosomal peaks. The automatically calculated RNA integrity number (RIN) allows classification of total RNA based on a numbering system from 1 to 10, with 1 being the most degraded profile and 10 being the most intact [32] .
Reverse Transcription
Total cellular RNA was reverse transcribed to cDNA in a volume of 60 ll containing 1 lg RNA, 2.5 lmol/ml random hexamers (Gibco BRL, Grand Island, NY), and moloney murine leukemia virus (M-MLV) reverse transcriptase (200 U/ll; Promega), as described previously by Pfaffl et al. [41] . A negative control reverse transcription reaction (in which the reverse transcription enzyme was replaced by water) was performed to detect residual DNA contamination. Reference or EMBL acc no.
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Real-Time PCR
Primers for housekeeping genes, ubiquitin and glycerolaldehyde-3-phosphate-dehydrogenase (GAPDH), and examined factors (progesterone receptor [PGR], OXT, OXT receptor [OXTR], IGF1, IGFBP1, ANGPT1, ANGPT2), were designed using the EMBL database or used according to the literature (Table 1) . Quantitative fluorescence real-time RT-PCR analysis was performed with the Rotor-Gene 3000 system (Corbett Research, Sydney, NSW, Australia). Online PCR reactions were carried out using a LightCycler DNA Master SYBR Green I kit (Roche Diagnostics) with 1 ll of each cDNA (16.66 ng) in a 10-ll reaction mixture (3 mmol/L MgCl 2 , 0.4 lmol/L of each forward and reverse primer, 13 LightCycler DNA Master SYBR Green I). After initial incubation at 958C for 10 min to activate Taq DNA polymerase, templates of all specific transcripts were amplified for 40 cycles at 958C for 10 sec, followed by annealing temperatures between 598C and 638C (according to the primer used) every 10 sec, and elongation at 728C for 15 sec. Fluorescence data were acquired after each elongation step by SYBR Green binding to the amplified dsDNA at 728C for 5 sec. The specificity of each PCR product was determined by melting curve analysis (Rotor-Gene 3000 software, version 5.03) immediately after PCR completion by heating at 958C for 5 sec, followed by cooling to 658C for 5 sec, and continuous heating to 998C at 0.58C/sec under permanent fluorescence detection. Confirmation of PCR product identity was obtained through melting curve analysis (RotorGene 3000) and subsequent gel electrophoresis separation. Data were analyzed using the Rotor-Gene 3000 software (version 5.03). The relative level of each target gene was calculated by the ''comparative quantification'' method (''Takeoff'' points). The changes in mRNA level of examined factors were assayed by normalization to the GAPDH internal control [44] . In order to obtain the cycle threshold difference (DCP), the GAPDH-normalized data were analyzed by the DDCP method described previously by Livak and Schmittgen [45] . Therefore, DCP was not subtracted from a control group, but from the value 40 (arbitrary value), so that a high 40 À DCP value indicated a high gene expression level, and vice versa [32] .
Statistical Analyses
The study was conducted on 40 cows, which were divided into eight groups (n ¼ 5 per group). All experimental data presented are shown as means 6 SEM. Statistical differences in mRNA levels and protein concentrations of the factors examined were analyzed by ANOVA, followed by Fisher least significant difference test as a multiple comparisons test. Differences were considered significant if P , 0.05.
RESULTS
Progesterone Blood Levels During Induced Luteolysis
Prior to PTGF injection, peripheral plasma concentrations of progesterone were 5.10 6 1.38 ng/ml (mean 6 SEM), but decreased to 1.6 6 0.65 and 0.55 6 0.43 ng/ml at 12 and 48 h, respectively, after PTGF administration. Progesterone concentrations less than 1.0 ng/ml are at basal levels, and are considered to reflect luteolysis or the absence of a functional CL. Thus, the measured progesterone levels demonstrate the efficiency of induced luteolysis.
RNA Quality Determination
RIN values of the samples collected during induced luteolysis ranged between 6.3 and 9.4. All samples revealed two distinct ribosomal peaks, corresponding to 18S and 28S for eukaryotic RNA. Only one sample (from a total of 45 samples) showed slight degradation, but gave comparable results as the other samples and was for us without concern for the gene expression level of all investigated factors [32] .
Confirmation of Primer Specificity and Sequence Analysis
The mRNA expression was analyzed by real-time RT-PCR (Rotor-Gene 3000). Initial RT-PCR experiments verified 942 specific transcripts for all factors in bovine CL. For exact length verification, RT-PCR products were separated on 2% high-resolution agarose gel electrophoresis. PCR products were verified by commercial DNA sequencing (TopLab, Munich, Germany). Each PCR product (Table 1) showed 100% homology to the known genes after sequencing.
Housekeeping Gene Expression
To evaluate equal quantity and quality of the preceding reverse transcription reaction in each sample, the housekeeping genes, ubiquitin and GAPDH, were examined in all samples. As both housekeeping genes were constantly expressed in all samples, we chose GAPDH as normalizer. The results of mRNA expression of the examined factors (Figs. 1-4 ) are presented as changes (40 À DCP 6 SEM from 5 CL per group) in the target gene expression, normalized to GAPDH.
Expression of mRNA and Peptide Concentration of Examined Factors
Luteotropic factors. Luteal progesterone concentrations and PGR mRNA expression levels are shown in Figure 1 . Progesterone concentrations (Fig. 1a) , as well as mRNA expression of PGR, in CL tissue (Fig. 1b) were significantly down-regulated by 12 h after PTGF administration.
Concentrations of luteal OXT rapidly declined and were significantly lower at 0.5 h before declining further at 2 h post-PTGF, and remained at these low levels thereafter (Fig. 2a) . However, its OXTR mRNA expression declined after 2 h to a significant lower plateau (Fig. 2c) , and remained at these low levels thereafter.
IGF1 peptide concentrations rapidly declined after 0.5 h, and remained at this low level until the end of the experiment (Fig. 3a) . In contrast, IGF1 mRNA was up-regulated at 0.5 h before decreasing at 2 h, and then remained at that low level for the remaining time (Fig. 3b) . By contrast, the IGFBP1 mRNA was up-regulated significantly after 2 h to a high plateau for 24 h, but was rapidly down-regulated thereafter (Fig. 3c) . 
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Angiogenic factors. The concentrations of VEGFA protein measured in CL extract supernatant by RIA are shown in Figure 4a . There was a significant decrease in VEGFA protein concentration by 0.5 h after PTGF administration, with a further decrease after 24 h.
There was a large, transient increase (approximately 3-fold) in the concentrations of luteal ANGPT2 protein at 0.5 and 2 h. However, ANGPT2 concentrations decreased at 4 h, and returned to concentrations similar to those before PTGF administration (Fig. 4b) . A comparable tendency was found for ANGPT2 mRNA (Fig. 4c ). By contrast, the level of ANGPT1 mRNA did not change (data not shown), and, therefore, the ratio for ANGPT2/ANGPT1 showed a similar pattern as for ANGPT2 mRNA (Fig. 4d) .
DISCUSSION
The luteolytic process in cow induced by PTGF surge consists of two phases: functional (first 12 h) and structural (after 12 h) luteolysis, which are reflected predominantly by a decrease in progesterone and a decrease in luteal size, respectively [46] . The decrease in progesterone blood levels in our experiment confirmed the occurrence of induced luteolysis. PTGF treatment showed acute effects on the investigated luteotropic factors (progesterone, PGR, OXT, OXTR, IGF1) and antiluteotropic factor, IGFBP1, as well as capillary-maintaining factors (VEGFA, ANGPT1, and ANGPT2), during functional luteolysis of the CL.
In the present study, progesterone concentration in blood serum and in CL tissue, as well as mRNA expression of PGR in CL tissue, were significantly down-regulated at 12 h after PTGF. As shown in an earlier study [47] , blood progesterone already decreased significantly 4 h after PTGF administration. Similarly, in the present study, luteal progesterone tissue concentration also tended to decrease after 4 h. It is well established that progesterone concentrations decrease during the first 12 h after PTGF administration, but progesterone may also have direct effects on its own production [48] . For example, Rueda et al. [49] showed that decreased progesterone level and PGR antagonists promote apoptotic cell death in bovine luteal cells. Progesterone seems to act on the secretory function of bovine CL via genomic (intracellular) receptors (a well-documented process), but also nongenomically (by membrane receptors). The nature of nongenomic action of progesterone is not fully understood [50, 51] .
OXT peptide concentrations in the present study rapidly declined immediately after 0.5 h and 2 h, by nearly 90%, while its receptor (OXTR) mRNA expression decreased 2 h after 944 PTGF administration to a low level thereafter. PTGF might also have stimulated the release of OXT from the CL as part of the luteolytic positive-feedback loop [47] . In contrast, it took longer for OXT mRNA expression to begin to decrease (only after 12 h). However, the low level of luteal OXT protein at this time suggests that there is either a decrease in protein stability or no new translation into protein. There are clear indications that OXT has intraovarian direct effects on steroidogenesis [52] . For example, OXT had the greatest effect on progesterone secretion after perfusion in the microdialysis system (MDS) of the early luteal phase (Days 5-7) CL, and decreased continuously from Days 8-12 to Days 15-18 [52] . Furthermore, OXT had a modulating action on LH stimulation of progesterone secretion in vitro [53] . Namely, in the MDS, administration of LH stimulated the release of progesterone throughout the luteal phase, with maximal effects on Days 15-18. By contrast, prestimulation with OXT prior to LH perfusion increased the stimulative effect of LH in the early luteal phase. The results support the assumption that OXT may be a potent luteotropic factor in bovine CL, especially during the developing phase [54] .
In the present study, IGF1 peptide concentrations rapidly declined after 0.5 h, and remained at this low level until the end of the experiment. Our previous studies [24] showed that the highest mRNA expression for IGF1 and IGF2 was observed during the early luteal phase (Days 1-4) of the bovine CL. However, luteal IGF1 protein concentrations were highest on Days 12-17 [55] . In vitro data using the MDS demonstrated that IGF1 stimulated progesterone and OXT secretion in a CL stage-specific manner. Namely, IGF1 had long-lasting effects even after the perfusion was stopped, particularly during the late luteal phase and early pregnancy [56] . Since the proteins for IGF1 and IGF1 receptor (IGF1R) [24] are mainly localized in large luteal cells, the regulation seems to be, at least in part, an autocrine action. As described previously by us [24] , there is clear evidence for mRNA expression for all six IGFBPs in CL, with IGFBP1 mRNA expression being relatively low during most of the estrous cycle. However, during PTGF-induced luteolysis, Sayre et al. [57] found a dramatic increase in IGFBP1 mRNA and protein in the cow. This is in strong agreement with our previous observations [25] and the present study, which noted an even earlier (0.5 h) up-regulation. Of all the IGFBPs studied, only IGFBP1 showed such a large and early up-regulation, while IGFBP3 mRNA declined after 12 h, and IGFBP5 mRNA increased 12 h onward. In addition, the IGF1R mRNA decreased shortly after PTGF administration, and again after 12 h [25] . The increase (about 34-fold) of IGFBP1 may cause a further reduction in bioactive free IGF1 in CL tissue. The acute decrease in the concentration of the local luteotropic factors OXT and IGF1 within 0.5 h as well as the massive increase in IGFBP1 in the CL after 0.5 h of luteolysis being induced may represent one of the important initial luteolytic actions of PTGF.
The described actions of PTGF on local luteotropic factors suggest negative effects on luteal cells. The survival of these cells depends on a fully functioning capillary network. One of the most important factors regulating new capillary formation, survival, and endothelial cell permeability is VEGFA [2, 4, [15] [16] . Previously, we have shown [17] that mRNA expression starts to decline 12 h after PTGF. However, in the present study, VEGFA protein concentrations had already declined (about 60%) by 0.5 h after the PTGF injection. This rapid decline of VEGFA protein appears to be an acute (releasing) effect of PTGF. The remaining low protein level in the tissue suggests a decrease in protein stability or no new translation of protein, even when the mRNA levels remain high for up to 12 h. A very interesting observation was the up-regulation of ANGPT2 mRNA and protein, indicating a very rapid translation of the protein. The mRNA data for both ANGPTs and receptors have already been published, in part, by Tanaka et al. [21] . Both ANGPTs are important for blood capillary stabilization, which depends on the ratio of ANGP-T2:ANGPT1. If the ANGPT2:ANGPT1 ratio is high, as it is 2 h after PTGF administration, and VEGFA is either absent or at low levels, then this will lead to blood vessel destabilization and regression [58] . This appears to be the case during early luteolysis after exogenous PTGF. Recently, mRNA expression of ANGPT1 was unaffected, but ANGPT2 increased at 8 h after PTGF-induced luteolysis in sheep [59] . Subsequently, 24 h after PTGF injection, ANGPT2 mRNA decreased when compared with the 8-h levels. This may indicate a different time frame for luteolysis in cows and sheep.
Taking together the very acute decrease of protein for the luteal cell luteotropic and antiapoptotic factors (OXT, IGF1, progesterone), as well as for the main survival factor for endothelial cells (VEGFA), suggests that the decrease may be one of the earliest steps for functional luteolysis after exogenous PTGF. As shown in sheep [59] , the number of cells undergoing apoptosis increased at 12 h after PTGF treatment, which was associated with the decrease in the number of endothelial cells. Sawyer et al. [60] postulated that, during luteal regression, endothelial cell number are reduced first, followed by a decline of parenchymal cells.
We have combined our current data with earlier results into a schematic representation of the physiological events that occur during luteal regression (Fig. 5) . The other cascades connected with PTGF-induced luteolysis are 1) luteal nitric oxide release and blood flow, 2) up-regulation of inflammatory cytokines and luteal cell apoptosis factors, 3) strong upregulation of vasoactive peptides in luteal cells, and 4) extracellular matrix proteases associated with CL tissue remodeling.
In conclusion, the acute changes of vasoactive key factors suggest that modulation of vascular stability is a key component in the cascade of events leading to functional luteolysis. This process is accompanied by parallel or slightly delayed apoptosis signaling cascades, and the initiation of factors associated with inhibition of capillary function. These changes culminate at the end of functional luteolysis (12 h) or during early structural luteolysis.
